37
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Concomitant Use of an Active Boosted Protease Inhibitor with Enfuvirtide in Treatment-Experienced, HIV-Infected Individuals: Recent Data and Consensus Recommendations

, , , , , , , , , , , , , , , , , , , & show all
Pages 86-96 | Published online: 02 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Jaran Eriksen, Christina Carlander, Jan Albert, Leo Flamholc, Magnus Gisslén, Lars Navér, Veronica Svedhem, Aylin Yilmaz & Anders Sönnerborg. (2020) Antiretroviral treatment for HIV infection: Swedish recommendations 2019. Infectious Diseases 52:5, pages 295-329.
Read now
Jaran Eriksen, Jan Albert, Anders Blaxhult, Christina Carlander, Leo Flamholc, Magnus Gisslén, Filip Josephson, Olof Karlström, Lars Navér, Veronica Svedhem, Aylin Yilmaz & Anders Sönnerborg. (2017) Antiretroviral treatment for HIV infection: Swedish recommendations 2016. Infectious Diseases 49:1, pages 1-34.
Read now
Filip Josephson, Jan Albert, Leo Flamholc, Magnus Gisslén, Olof Karlström, Lars Moberg, Lars Navér, Veronica Svedhem, Bo Svennerholm & Anders Sönnerborg. (2009) Treatment of HIV infection: Swedish recommendations 2009. Scandinavian Journal of Infectious Diseases 41:11-12, pages 788-807.
Read now
Christina MR Kitchen, Miriam Nuño, Scott G Kitchen & Paul Krogstad. (2008) Enfuvirtide antiretroviral therapy in HIV-1 infection. Therapeutics and Clinical Risk Management 4:2, pages 433-439.
Read now
Franco Maggiolo, Diego Ripamonti, Monica Airoldi, Annapaola Callegaro, Claudio Arici, Veronica Ravasio, Enrico Bombana, Antonio Goglio & Fredy Suter. (2007) Resistance Costs and Future Drug Options of Antiretroviral Therapies: Analysis of the Role of NRTIs, NNRTIs, and PIs in a Large Clinical Cohort. HIV Clinical Trials 8:1, pages 9-18.
Read now
Filip Josephson, Jan Albert, Leo Flamholc, Magnus Gisslén, Olof Karlström, Susanne-Rosa Lindgren, Lars Navér, Eric Sandström, Veronica Svedhem-Johansson, Bo Svennerholm & Anders Sönnerborg. (2007) Antiretroviral treatment of HIV infection: Swedish recommendations 2007. Scandinavian Journal of Infectious Diseases 39:6-7, pages 486-507.
Read now

Articles from other publishers (13)

Anne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, Diane Descamps, Laurence Morand-Joubert, Corinne Amiel, Veronique Schneider, Virginie Ferre, Jacques Izopet, Ali Si-Mohamed, Anne Maillard, Cécile Henquell, Delphine Desbois, Mouna Lazrek, Anne Signori-Schmuck, Sylvie Rogez, Sabine Yerly, Mary-Anne Trabaud, Jean-Christophe Plantier, Slim Fourati, Allal Houssaini, Bernard Masquelier, Vincent Calvez & Philippe Flandre. (2013) A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure. International Journal of Antimicrobial Agents 42:1, pages 42-47.
Crossref
Hadija H Semvua & Gibson S Kibiki. (2011) AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus. BMC Research Notes 4:1.
Crossref
Regina B. OsihPatrick TafféMartin RickenbachAngèle Gayet–AgeronLuigia ElziChristoph FuxMilos OpravilEnos BernasconiPatrick SchmidHuldrych F GünthardMatthias Cavassini. (2010) Outcomes of Patients on Dual-Boosted PI Regimens: Experience of the Swiss HIV Cohort Study. AIDS Research and Human Retroviruses 26:11, pages 1239-1246.
Crossref
Brian Conway. (2009) HAART in treatment-experienced patients in the 21st century: the audacity of hope. Future Virology 4:1, pages 39-41.
Crossref
Roy T. SteigbigelDavid A. CooperPrincy N. KumarJoseph E. EronMauro SchechterMartin MarkowitzMona R. LoutfyJeffrey L. LennoxJose M. GatellJurgen K. RockstrohChristine KatlamaPatrick YeniAdriano LazzarinBonaventura ClotetJing ZhaoJoshua ChenDesmond M. RyanRand R. RhodesJohn A. KillarLucinda R. GildeKim M. StrohmaierAnne R. MeibohmMichael D. MillerDaria J. HazudaMichael L. NesslyMark J. DiNubileRobin D. IsaacsBach-Yen NguyenHedy Teppler. (2008) Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection. New England Journal of Medicine 359:4, pages 339-354.
Crossref
Graeme MoyleJose GatellCarlo-Federico PernoWinai RatanasuwanMauro SchechterChristos Tsoukas. (2008) Potential for New Antiretrovirals to Address Unmet Needs in the Management of HIV-1 Infection. AIDS Patient Care and STDs 22:6, pages 459-471.
Crossref
Jacob P. LalezariMichael SaagCharles WalworthPeter Larson. (2008) An Open-Label Safety Study of Enfuvirtide Injection with a Needle-Free Injection Device or Needle/Syringe: The Biojector 2000 Open-Label Safety Study (BOSS). AIDS Research and Human Retroviruses 24:6, pages 805-813.
Crossref
Alessandro Soria, Mariangela Cavarelli, Stefania Sala, Anna Ida Alessandrini, Gabriella Scarlatti, Adriano Lazzarin & Antonella Castagna. (2008) Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutations. Journal of Medical Virology 80:6, pages 937-941.
Crossref
Carlo‐Federico Perno, Graeme Moyle, Chris Tsoukas, Winai Ratanasuwan, Jose Gatell & Mauro Schechter. (2008) Overcoming resistance to existing therapies in HIV‐infected patients: The role of new antiretroviral drugs. Journal of Medical Virology 80:4, pages 565-576.
Crossref
Nils Von Hentig, Errol Babacan, Schlomo Staszewski, Martin Stürmer, Hans W Doerr & Jörn Lötsch. (2007) Predictive Factors for Response to a Boosted Dual HIV-Protease Inhibitor Therapy with Saquinavir and Lopinavir in Extensively Pre-Treated Patients. Antiviral Therapy 12:8, pages 1237-1246.
Crossref
Alessandro Soria & Adriano Lazzarin. (2007) Antiretroviral Treatment Strategies and Immune Reconstitution in Treatment-naive HIV-Infected Patients with Advanced Disease. JAIDS Journal of Acquired Immune Deficiency Syndromes 46:Suppl 1, pages S19-S30.
Crossref
Yasuhiro Koh, Shintaro Matsumi, Debananda Das, Masayuki Amano, David A. Davis, Jianfeng Li, Sofiya Leschenko, Abigail Baldridge, Tatsuo Shioda, Robert Yarchoan, Arun K. Ghosh & Hiroaki Mitsuya. (2007) Potent Inhibition of HIV-1 Replication by Novel Non-peptidyl Small Molecule Inhibitors of Protease Dimerization. Journal of Biological Chemistry 282:39, pages 28709-28720.
Crossref
Rodger D MacArthur. (2007) Darunavir: promising initial results. The Lancet 369:9568, pages 1143-1144.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.